InSphero
Latest InSphero Content
Product News
InSphero Partners With Chayon To Bring Advanced 3D In Vitro Technologies to South Korean Researchers
InSphero announced its distribution partnership with Chayon. This partnership will bring InSphero’s reliable and scalable 3D in vitro solutions for drug development to South Korean researchers.
Product News
InSphero Secures Exclusive Commercialization Partnership With Genome Biologics for 3D Cardiac Organoid Platform
InSphero AG is pleased to announce its exclusive commercialization partnership with Genome Biologics, based in Frankfurt, Germany.
Product News
InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery
InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.
Industry Insight
Bridging Academia and Industry: The Evolution of 3D Models in Drug Development
The industry's search for alternatives to traditional preclinical drug testing methods has led to a growing interest in the potential of three-dimensional (3D) in vitro models. To delve deeper into this subject, Technology Networks spoke with Madhu Lal-Nag, chief scientific officer at InSphero, a 3D in vitro model company with a mission to “modernize drug discovery in ways that inspire researchers everywhere to reach their full potential and fuel a new era of breakthrough therapies.”
Advertisement